CV Sciences Inc (CVSI)

[Chirodoctor]

It be very difficult to imagine a scenario where we were denied NASDAQ up listing. This is been going on since July 2018.

If we were denied we would know it by now as a matter of fact we would know it long ago. Being one of the two leading companies in exploding industry with fantastic financials you would think would be a shoo-in but I’m sure NASDAQ wants to hear how the FDA is going to regulate CBD. More states are now allowing it to be added to foods and beverages.

I suspect when we get up listed us small timers will be chasing the stock at Eight dollars, $8.50, nine dollars, $9.50 as the big boys gobble this thing up.